Shanghai Junshi Biosciences Co Ltd (688180) - Total Liabilities

Latest as of September 2025: CN¥5.39 Billion CNY ≈ $789.12 Million USD

Based on the latest financial reports, Shanghai Junshi Biosciences Co Ltd (688180) has total liabilities worth CN¥5.39 Billion CNY (≈ $789.12 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how efficiently does Shanghai Junshi Biosciences Co Ltd generate cash to assess how effectively this company generates cash.

Shanghai Junshi Biosciences Co Ltd - Total Liabilities Trend (2014–2024)

This chart illustrates how Shanghai Junshi Biosciences Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check 688180 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

Shanghai Junshi Biosciences Co Ltd Competitors by Total Liabilities

The table below lists competitors of Shanghai Junshi Biosciences Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Sinomach Heavy Equipment Group Co Ltd SHG:601399	China	CN¥18.98 Billion
Sinotrans Ltd Class A SHG:601598	China	CN¥39.26 Billion
LegoChem Biosciences Inc KQ:141080	Korea	₩136.37 Billion
TG Therapeutics Inc NASDAQ:TGTX	USA	$417.81 Million
LEG Immobilien SE XETRA:LEG	Germany	€12.40 Billion
Crocs Inc NASDAQ:CROX	USA	$2.94 Billion
Persimmon Plc F:OHP	Germany	€1.51 Billion

Liability Composition Analysis (2014–2024)

This chart breaks down Shanghai Junshi Biosciences Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Shanghai Junshi Biosciences Co Ltd market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.62	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.87	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.46	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Shanghai Junshi Biosciences Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Shanghai Junshi Biosciences Co Ltd (2014–2024)

The table below shows the annual total liabilities of Shanghai Junshi Biosciences Co Ltd from 2014 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥4.85 Billion ≈ $709.68 Million	+20.57%
2023-12-31	CN¥4.02 Billion ≈ $588.58 Million	+44.58%
2022-12-31	CN¥2.78 Billion ≈ $407.10 Million	+2.34%
2021-12-31	CN¥2.72 Billion ≈ $397.81 Million	+25.30%
2020-12-31	CN¥2.17 Billion ≈ $317.48 Million	+51.31%
2019-12-31	CN¥1.43 Billion ≈ $209.83 Million	+53.17%
2018-12-31	CN¥936.18 Million ≈ $136.99 Million	+832.68%
2017-12-31	CN¥100.38 Million ≈ $14.69 Million	+347.80%
2016-12-31	CN¥22.41 Million ≈ $3.28 Million	+58.27%
2015-12-31	CN¥14.16 Million ≈ $2.07 Million	+8.34%
2014-12-31	CN¥13.07 Million ≈ $1.91 Million	--

About Shanghai Junshi Biosciences Co Ltd

SHG:688180 China Biotechnology

Market Cap

$4.52 Billion

CN¥30.91 Billion CNY

Market Cap Rank

#3835 Global

#626 in China

Share Price

CN¥40.38

Change (1 day)

+0.20%

52-Week Range

CN¥28.43 - CN¥48.80

All Time High

CN¥151.00